Table 4.

Antifungal Therapy Used During Index Encounter of 604 Patients With Candida Infective Endocarditis Who Had Available Medication Administration Data

Available Medication Administration Data	N = 604
Received Antifungal Therapy	591 (97.8%)
Amphotericin	213 (35.3%)
Amphotericin B (Fungizone)	28 (4.6%)
Amphotericin B lipid complex (ABELCET)	27 (4.5%)
Amphotericin B liposome (AmBisome)	165 (27.3%)
Echinocandin	488 (80.8%)
Anidulafungin	30 (5.0%)
Caspofungin	86 (14.2%)
Micafungin	375 (62.1%)
Fluconazole	376 (62.3%)
Flucytozine	111 (18.4%)
Posaconazole	<10 (<1.7%)
Voriconazole	53 (8.8%)
Isavuconazole	<10 (<1.7%)

NOTE: Subjects may have received >1 drug. Some patients received more than 1 antifungal agent.